Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700460 · ClinicalTrials.gov registry record · NA
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
A NA study of Myopia, sponsored by Vance Thompson Vision.
- Recruiting
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 5
- Study locations
NCT06700460: Recruiting NA study of Myopia, sponsored by Vance Thompson Vision.
NCT06700460 is a NA study of Myopia that is actively recruiting participants, run by Vance Thompson Vision. The registered enrollment target is 56 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (79% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06700460, a NA study of Myopia, is actively recruiting participants, sponsored by Vance Thompson Vision.
- RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 5
- Study locations
Study Summary
Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
Primary Outcome
Uncorrected distance visual acuity and Corrected distance visual acuity
Conditions Studied
Interventions
- DEVICE Laser-assisted in Situ Keratomileusis
- DEVICE Implantable Collamer Lens placement
Study Locations (5)
Nebraska
- Kugler Vision - Omaha
Ohio
- Cleveland Eye Clinic - Cleveland
South Carolina
- Carolina Eyecare Physicians - Mt. Pleasant
South Dakota
- Vance Thompson Vision Clinic - Sioux Falls
Texas
- Slade & Baker Vision - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-11-27 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
What NCT06700460 shows while recruiting
NCT06700460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Laser-assisted in Situ Keratomileusis is the first listed.
NCT06700460 lists 5 locations in 5 states (Nebraska, Ohio, South Carolina).
Frequently Asked Questions
What is clinical trial NCT06700460 about?
NCT06700460 is a clinical study titled "Measuring Outcomes of LASIK and EVO-ICL in Matched Populations". Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
What is the current status of trial NCT06700460?
This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2024-11-27. Estimated completion is 2025-04-01.
What conditions does trial NCT06700460 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT06700460?
The interventions under investigation include: Laser-assisted in Situ Keratomileusis (DEVICE), Implantable Collamer Lens placement (DEVICE).
Who is sponsoring clinical trial NCT06700460?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06700460 being conducted?
This trial has 5 study locations across Nebraska, Ohio, South Carolina, South Dakota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06700460's enrollment target sits among peer trials
56 63rd of 90 higher than 28 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI